HelpLine 1-800-298-2436

LCA Announces Appointment Of The Honorable Clay Shaw (R-Fl), To Its Honorary Board Of Directors

Washington, DC [September  26, 2011]—Today Lung Cancer Alliance (LCA) announced that The Honorable Clay Shaw (R-FL), will be joining  LCA's  Honorary Board of Directors.

He joins The Honorable Chuck Hagel (R-NE), former U.S. Senator, Co-Chair of the President’s Intelligence Advisory Board, Professor of Foreign Policy at Georgetown University and the University of Nebraska, J. Steven Hart, Esq., former LCA President and President & CEO, Williams and Jensen, and Jane Reece-Coulbourne, Executive Director, Reagan-Udall Foundation.  

"This is a great honor and privilege to have Congressman Shaw join us in this capacity, said Laurie Fenton Ambrose, LCA President & CEO.  We established the Honorary Board to thank those who have taken strong public positions on the need to change public health policy and increase research funding for all aspects of lung cancer.”

“This is a wonderful opportunity to continue the work I began with this very special organization while in Congress to bring much needed focus, awareness and support to this disease—one that I know personally. Said Congressman Shaw, LCA is responsible for building the first-ever national network of congressional action and organizational support around lung cancer and I am glad to help contribute efforts to achieve better outcomes for all those affected by lung cancer”.  
 
Congressman Shaw was elected to Congress in 1980 and was re-elected to 13 consecutive terms.  Shaw, an attorney, first served on the Judiciary Committee where he concentrated on anti -narcotics legislation.   In 1988 he won assignment to the Ways and Means Committee where his concentration expanded to seniors, health and welfare issues.  Shaw was best known for his efforts at reforming the welfare system.   

Fenton-Ambrose continued, “Congressman Shaw was a leader on so many legislative fronts --- including lung cancer policy – during his tenure in the House of  Representatives.  He was a staunch advocate for critically needed federal research funding for screening and treatments.  He led bipartisan efforts to petition the National Cancer Institute (NCI) to make lung cancer a research priority.  He introduced first-ever legislation to provide coverage for lung cancer screening tests for certain high-risk individuals under the Medicare Program.  And he called upon Congress to officially recognize November as Lung Cancer Awareness Month.

Fenton-Ambrose continued, “as a lung cancer survivor himself, we are delighted that Congressman Shaw remains committed to helping LCA elevate national awareness and ensure a more compassionate and comprehensive federal plan of action is developed for all those affected by this disease”.   

Lung Cancer Alliance (www.LungCancerAlliance.org) is the only national non-profit organization dedicated exclusively to patient support and advocacy for those living with or at risk for lung cancer.  Lung Cancer Alliance is committed to leading the movement to reverse decades of stigma and neglect by empowering those with or at risk for the disease, elevating awareness and changing health policy.